Despite significant advancements in treatment, multiple myeloma remains an incurable disease, and nearly all patients experience relapse, often requiring increasingly complex therapeutic strategies.
With the rapid expansion of treatment options, particularly novel targeted therapies such as GPRC5D-directed approaches, the landscape of relapsed/refractory multiple myeloma (RRMM) management is evolving at an unprecedented pace. While these agents offer deep and durable remissions, their integration into clinical practice presents challenges in sequencing, toxicity management, and multidisciplinary coordination.
This educational initiative is designed to empower clinicians with the latest insights on GPRC5D-targeted therapies, facilitate the exchange of real-world clinical experience, and provide actionable strategies for optimizing patient outcomes. Through interactive discussions and expert-led guidance, participants will gain practical knowledge to navigate the complexities of RRMM treatment while fostering collaborative networks to enhance long-term patient care.
Join us to stay at the forefront of innovation in multiple myeloma management and elevate your clinical practice.
CME/CE Accreditation Information
This curriculum on Comprehensive Approaches to Addressing Atopic Dermatitis in Very Young Patients is designed to equip healthcare professionals with a thorough understanding of effective strategies for managing and treating atopic dermatitis in infants and toddlers. This program integrates the latest medical research and practical insights to ensure participants gain comprehensive knowledge and skills necessary to provide optimal care for this vulnerable patient population.
CME/CE Accreditation Information
This curriculum is designed to empower neurologists, epileptologists, and pediatricians with the knowledge to address the unique challenges posed by Developmental and Epileptic Encephalopathies (DEEs). Through a blend of self-study modules, live discussions, and action planning, participants will learn to optimize care for DEE patients by understanding the impact of anti-seizure medications on both seizure and non-seizure symptoms.
CME/CE Accreditation Information
This small group educational experience is designed for clinicians involved in the management of Eosinophilic Esophagitis (EoE). It aims to deepen knowledge of EoE by exploring current treatment modalities, disease characteristics, and therapeutic outcomes. This program will also delve into evolving treatment paradigms and the significance of diagnostic imaging in the context of EoE management.
CME/CE Accreditation Information
This curriculum is designed to enhance knowledge, competence, and confidence among oncology clinicians regarding second-line therapy for small cell lung cancer (SCLC). Learners will explore evidence-based treatment sequencing, adverse event management, and emerging clinical trial data to optimize patient outcomes.
CME/CE Accreditation Information
This curriculum provides practical guidance on the diagnosis and management of eosinophilic esophagitis (EoE), a chronic, immune-mediated disease of the esophagus with rising prevalence. Learners will engage with current diagnostic algorithms, examine treatment options including dietary therapy, topical corticosteroids, and biologics, and explore strategies to meet payer documentation requirements for timely access to care. Designed for gastroenterologists, allergists, and other clinicians involved in the care of patients with EoE, the program emphasizes accurate diagnosis, coordinated multidisciplinary care, and personalized, evidence-based treatment planning.
CME/CE Accreditation Information
Postpartum depression (PPD) affects up to one in seven women and is a leading cause of maternal morbidity, with profound implications for both the patient and her family. Untreated PPD can lead to chronic depression, impaired maternal-infant bonding, strained partner relationships, and long-term developmental challenges for the child. These effects are magnified when symptoms go unrecognized or untreated. Early and routine screening, integrated into obstetric and pediatric care, is essential to identify women at risk and initiate timely intervention. Collaborative care models where primary care or OB providers partner with behavioral health care managers and consulting psychiatrists offer a scalable, evidence-based approach to managing PPD. These models improve access to treatment, ensure close follow-up, and have demonstrated superior outcomes compared to standard care.
CME/CE Accreditation Information
This interactive program equips neurology providers with practical strategies to improve care for patients with myasthenia gravis. Grounded in real-world clinical challenges, the content focuses on early identification of high-risk patients, individualized treatment planning, and effective integration of newly approved and emerging therapies. Participants will gain insights that can be immediately applied to enhance outcomes across the spectrum of myasthenia gravis severity.
CME/CE Accreditation Information
This online program on idiopathic hypersomnia provides healthcare professionals with an in-depth understanding of this complex sleep disorder, including its pathophysiology, diagnosis, and management strategies. Through expert-led presentations and case-based discussions, participants will gain practical insights to improve patient outcomes in clinical practice.
CME/CE Accreditation Information
Welcome to this curriculum on the diagnosis and management of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). This program is designed to provide you with the latest strategies for accurately diagnosing, staging, and treating GEP-NETs by integrating pathological grading with advanced imaging and novel systemic therapies. This activity emphasizes a collaborative approach, encouraging multidisciplinary care coordination to personalize treatment plans and optimize outcomes for patients with this complex disease.
CME/CE Accreditation Information
